Phaxiam Therapeutics Sa (NASDAQ: PHXM) is owned by 0.02% institutional shareholders, 0.00% Phaxiam Therapeutics Sa insiders, and 99.98% retail investors. Asset Dedication LLC is the largest individual Phaxiam Therapeutics Sa shareholder, owning 400.00 shares representing 0.01% of the company. Asset Dedication LLC's Phaxiam Therapeutics Sa shares are currently valued at $1.68k.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.